Structures by: McArdle P.
Total: 165
C13H18N3O4
C13H18N3O4
Organic letters (2015) 17, 24 6226-6229
a=6.1187(2)Å b=15.5628(7)Å c=7.4298(3)Å
α=90° β=90.617(4)° γ=90°
C17H22NO3S
C17H22NO3S
Organic letters (2015) 17, 24 6226-6229
a=8.5345(4)Å b=8.8037(4)Å c=11.0062(7)Å
α=90° β=90.369(5)° γ=90°
C27H20O7S
C27H20O7S
Organic letters (2017) 19, 21 5802-5805
a=10.2354(10)Å b=14.6975(11)Å c=16.2321(13)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0907(3)Å b=11.5779(4)Å c=22.8104(7)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1349(3)Å b=11.6868(4)Å c=22.8660(8)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0963(2)Å b=11.5574(3)Å c=22.8612(7)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1445(3)Å b=11.7130(3)Å c=22.8862(5)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1415(4)Å b=11.7002(4)Å c=22.8837(6)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1357(3)Å b=11.6782(3)Å c=22.8834(6)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1405(3)Å b=11.6923(2)Å c=22.8838(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1280(3)Å b=11.6579(3)Å c=22.8759(5)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1311(3)Å b=11.6667(2)Å c=22.8800(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1237(2)Å b=11.6442(2)Å c=22.8738(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1158(2)Å b=11.6222(2)Å c=22.8715(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1066(2)Å b=11.5983(2)Å c=22.8627(3)Å
α=90.00° β=90.00° γ=90.00°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1070(3)Å b=11.5902(3)Å c=22.8593(6)Å
α=90.00° β=90.00° γ=90.00°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1064(3)Å b=11.5845(3)Å c=22.8569(6)Å
α=90.00° β=90.00° γ=90.00°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1048(3)Å b=11.5802(3)Å c=22.8576(6)Å
α=90.00° β=90.00° γ=90.00°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0992(4)Å b=11.5635(3)Å c=22.8525(6)Å
α=90.00° β=90.00° γ=90.00°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0972(2)Å b=11.5751(2)Å c=22.8531(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0881(3)Å b=11.5538(2)Å c=22.8478(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0823(3)Å b=11.5422(2)Å c=22.8439(3)Å
α=90.00° β=90.00° γ=90.00°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1228(4)Å b=11.6522(6)Å c=22.8488(10)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.1074(3)Å b=11.6193(5)Å c=22.8456(9)Å
α=90° β=90° γ=90°
C11H12N4O2S
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.5040(2)Å b=8.21620(10)Å c=21.9984(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=9.0885(6)Å b=11.5482(7)Å c=22.7898(12)Å
α=90° β=90° γ=90°
C11H12N4O2S
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4973(2)Å b=8.21180(10)Å c=21.9658(3)Å
α=90° β=90° γ=90°
C11H12N4O2S
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.5008(2)Å b=8.21410(10)Å c=21.9821(4)Å
α=90° β=90° γ=90°
C11H12N4O2S
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.49500(10)Å b=8.20940(10)Å c=21.9489(3)Å
α=90° β=90° γ=90°
C11H12N4O2S
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.49140(10)Å b=8.20690(10)Å c=21.9332(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.48840(10)Å b=8.20480(10)Å c=21.9167(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.48520(10)Å b=8.20200(10)Å c=21.9002(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.48140(10)Å b=8.19930(10)Å c=21.8844(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.47950(10)Å b=8.19740(10)Å c=21.8693(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4763(2)Å b=8.19460(10)Å c=21.8522(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.47010(10)Å b=8.18890(10)Å c=21.8216(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.47340(10)Å b=8.19210(10)Å c=21.8397(3)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.46380(10)Å b=8.18350(10)Å c=21.7953(2)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.46660(10)Å b=8.18680(10)Å c=21.8103(2)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.45970(10)Å b=8.18020(10)Å c=21.7812(2)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4902(9)Å b=8.2249(6)Å c=22.0106(14)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.45880(10)Å b=8.18000(10)Å c=21.7664(2)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4899(5)Å b=8.2086(4)Å c=21.9106(9)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4829(6)Å b=8.1938(3)Å c=21.8441(9)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4687(6)Å b=8.1829(9)Å c=21.8084(4)Å
α=90° β=90° γ=90°
Sulfamerazine
C11H12N4O2S
Molecular Pharmaceutics (2015) 12, 3735-3748
a=14.4393(7)Å b=8.1764(4)Å c=21.7395(13)Å
α=90.00° β=90.00° γ=90.00°
C11H7Cl2F3N2O1.5
C11H7Cl2F3N2O1.5
Organic letters (2015) 17, 11 2856-2859
a=7.5010(7)Å b=40.025(5)Å c=16.7795(17)Å
α=90° β=94.664(9)° γ=90°
C10H7BrCl2N2O
C10H7BrCl2N2O
Organic letters (2015) 17, 11 2856-2859
a=12.6226(8)Å b=12.3709(9)Å c=14.1124(10)Å
α=90° β=90° γ=90°
C12H12Br2N2O
C12H12Br2N2O
Organic letters (2015) 17, 11 2856-2859
a=7.3945(9)Å b=20.124(3)Å c=17.430(2)Å
α=90° β=91.440(12)° γ=90°
C11H10Br2N2
C11H10Br2N2
Organic letters (2015) 17, 11 2856-2859
a=14.9133(11)Å b=10.5056(7)Å c=7.3297(8)Å
α=90° β=103.561(9)° γ=90°
C11H9Br2FN2
C11H9Br2FN2
Organic letters (2015) 17, 11 2856-2859
a=14.443(2)Å b=7.5861(12)Å c=21.306(3)Å
α=90° β=90° γ=90°
C44H28O14
C44H28O14
Journal of Chemical & Engineering Data (2015) 60, 7 2110
a=19.7826(11)Å b=11.0872(5)Å c=30.0405(17)Å
α=90° β=95.850(6)° γ=90°
C8H18ClNO
C8H18ClNO
Organic & biomolecular chemistry (2018) 16, 22 4108-4116
a=11.3190(18)Å b=10.9194(16)Å c=7.7658(10)Å
α=90° β=90.269(13)° γ=90°
C11H21ClN2O
C11H21ClN2O
Organic & biomolecular chemistry (2018) 16, 22 4108-4116
a=10.1121(7)Å b=10.4420(6)Å c=12.0205(14)Å
α=95.695(8)° β=91.086(8)° γ=97.671(5)°
C15H16N2O4
C15H16N2O4
Organic & Biomolecular Chemistry (2003) 1, 7 1122
a=8.4604(16)Å b=19.740(2)Å c=16.800(2)Å
α=90.00° β=90.00° γ=90.00°
C22H23NO5
C22H23NO5
Organic & Biomolecular Chemistry (2003) 1, 7 1122
a=15.243(6)Å b=8.697(4)Å c=15.245(10)Å
α=90.00° β=108.21(4)° γ=90.00°
C15H19NO5S
C15H19NO5S
Organic & biomolecular chemistry (2003) 1, 23 4302-4316
a=8.3850(10)Å b=11.2710(10)Å c=16.603(2)Å
α=90.00° β=90.00° γ=90.00°
C17H20NO5S
C17H20NO5S
Organic & biomolecular chemistry (2003) 1, 23 4302-4316
a=9.286(2)Å b=18.246(2)Å c=10.204(2)Å
α=90.00° β=90.77(2)° γ=90.00°
C23H20N2O5
C23H20N2O5
Organic & biomolecular chemistry (2006) 4, 12 2408-2416
a=7.5822(15)Å b=10.3689(13)Å c=13.0588(9)Å
α=90.275(9)° β=101.461(11)° γ=100.074(13)°
C19H15NO3
C19H15NO3
Organic & biomolecular chemistry (2006) 4, 12 2408-2416
a=7.4430(10)Å b=10.892(2)Å c=19.212(3)Å
α=82.95(2)° β=81.14(2)° γ=88.01(2)°
C20H18N2O2
C20H18N2O2
Organic & biomolecular chemistry (2006) 4, 12 2408-2416
a=7.4920(1)Å b=9.0450(2)Å c=13.5630(4)Å
α=73.159(1)° β=73.945(1)° γ=70.568(1)°
C20H18N2O5
C20H18N2O5
Chemical communications (Cambridge, England) (2020) 56, 42 5657-5660
a=10.0493(6)Å b=12.6674(11)Å c=14.6060(13)Å
α=79.358(7)° β=80.034(6)° γ=89.938(6)°
C64H44F8N4O14
C64H44F8N4O14
Chemical communications (Cambridge, England) (2020) 56, 42 5657-5660
a=27.197(5)Å b=3.7093(4)Å c=26.924(4)Å
α=90° β=94.626(16)° γ=90°
C36H24F4N2O6
C36H24F4N2O6
Chemical communications (Cambridge, England) (2020) 56, 42 5657-5660
a=3.7762(4)Å b=29.2094(16)Å c=13.5261(9)Å
α=90° β=96.309(7)° γ=90°
C36H48N6O6
C36H48N6O6
Chemical Communications (2019)
a=6.0407(3)Å b=21.1209(12)Å c=27.1076(14)Å
α=90° β=90° γ=90°
C9H18NO4
C9H18NO4
CrystEngComm (2020) 22, 3 412-415
a=11.7250(10)Å b=6.1271(4)Å c=16.0527(15)Å
α=90° β=99.628(9)° γ=90°
C15H23NO5
C15H23NO5
CrystEngComm (2020) 22, 3 412-415
a=30.706(2)Å b=9.6913(7)Å c=11.0426(9)Å
α=90° β=90° γ=90°
C18H36N2O8
C18H36N2O8
CrystEngComm (2020) 22, 3 412-415
a=11.5328(10)Å b=6.1123(5)Å c=16.0138(14)Å
α=90° β=99.780(9)° γ=90°
C15H23NO5
C15H23NO5
CrystEngComm (2020) 22, 3 412-415
a=9.5719(7)Å b=30.798(2)Å c=10.9331(9)Å
α=90° β=90° γ=90°
C313H317N24O77S16
C313H317N24O77S16
CrystEngComm (2020) 22, 1 14-17
a=33.621(17)Å b=38.411(13)Å c=40.234(15)Å
α=90° β=102.56(4)° γ=90°
C313H317N24O149.5S16
C313H317N24O149.5S16
CrystEngComm (2020) 22, 1 14-17
a=33.621(17)Å b=38.411(13)Å c=40.234(15)Å
α=90° β=102.56(4)° γ=90°
C9H9N3O2S2
C9H9N3O2S2
CrystEngComm (2010) 12, 10 3119
a=8.2241(4)Å b=8.5725(4)Å c=15.5081(7)Å
α=90.00° β=93.794(4)° γ=90.00°
C9H9N3O2S2
C9H9N3O2S2
CrystEngComm (2010) 12, 10 3119
a=10.5301(5)Å b=13.1928(9)Å c=17.040Å
α=90.00° β=107.961(5)° γ=90.00°
C9H9N3O2S2
C9H9N3O2S2
CrystEngComm (2010) 12, 10 3119
a=17.5911(11)Å b=8.5439(4)Å c=15.5940(10)Å
α=90.00° β=113.022(8)° γ=90.00°
C9H9N3O2S2
C9H9N3O2S2
CrystEngComm (2010) 12, 10 3119
a=10.8598(3)Å b=8.5347(2)Å c=11.4387(3)Å
α=90.00° β=91.941(2)° γ=90.00°
C9H9N3O2S2
C9H9N3O2S2
CrystEngComm (2010) 12, 10 3119
a=10.4125(5)Å b=15.2429(10)Å c=14.3121(6)Å
α=90.00° β=91.042(4)° γ=90.00°
C26H20O5W
C26H20O5W
Chemical Communications (2001) 16 1504
a=9.952(2)Å b=10.753(3)Å c=12.567(3)Å
α=66.63(2)° β=71.183(19)° γ=63.35(2)°
C20H17N3O2S
C20H17N3O2S
Chemical Communications (2001) 19 1950
a=12.524(2)Å b=11.088(3)Å c=12.935(2)Å
α=90.00° β=99.75(2)° γ=90.00°
C18H15N3S
C18H15N3S
Journal of the Chemical Society, Perkin Transactions 1 (2002) 24 2851
a=12.4385(19)Å b=6.0956(11)Å c=20.623(4)Å
α=90.00° β=102.514(13)° γ=90.00°
C13H11N3O2S
C13H11N3O2S
Journal of the Chemical Society, Perkin Transactions 1 (2002) 24 2851
a=10.537(2)Å b=11.710(4)Å c=12.259(2)Å
α=117.58(2)° β=99.770(10)° γ=99.90(2)°
C20H17N3O2S
C20H17N3O2S
Journal of the Chemical Society, Perkin Transactions 1 (2002) 24 2851
a=12.524(2)Å b=11.088(3)Å c=12.935(2)Å
α=90.00° β=99.75(2)° γ=90.00°
C24H27P
C24H27P
Dalton transactions (Cambridge, England : 2003) (2006) 46 5464-5475
a=7.4490(10)Å b=17.291(2)Å c=15.649(2)Å
α=90.00° β=99.290(10)° γ=90.00°
C24H27P
C24H27P
Dalton transactions (Cambridge, England : 2003) (2006) 46 5464-5475
a=10.737(2)Å b=12.291(2)Å c=15.286(2)Å
α=90.00° β=90.39(2)° γ=90.00°
C24H27OP
C24H27OP
Dalton transactions (Cambridge, England : 2003) (2006) 46 5464-5475
a=14.398(2)Å b=8.274(2)Å c=17.451(4)Å
α=90.00° β=101.973(16)° γ=90.00°
C15H17OP
C15H17OP
Dalton transactions (Cambridge, England : 2003) (2006) 46 5464-5475
a=8.2401(9)Å b=10.7830(9)Å c=15.5965(10)Å
α=90.00° β=102.280(10)° γ=90.00°
C18H23OP
C18H23OP
Dalton transactions (Cambridge, England : 2003) (2006) 46 5464-5475
a=7.518(2)Å b=13.085(2)Å c=16.660(8)Å
α=90.00° β=90.00° γ=90.00°
Methyl-bis(2-methylphenyl)phosphinesulphide
C15H17PS
Dalton transactions (Cambridge, England : 2003) (2006) 46 5464-5475
a=13.974(3)Å b=6.7730(10)Å c=15.790(4)Å
α=90.00° β=111.380(10)° γ=90.00°
C27H33P
C27H33P
Dalton transactions (Cambridge, England : 2003) (2006) 46 5464-5475
a=11.005(2)Å b=12.990(3)Å c=18.795(5)Å
α=75.89(2)° β=88.14(2)° γ=69.87(2)°
Pentacarbonyl(methylbis(2-methylphenyl)phosphine)chromium
C20H17CrO5P
Dalton transactions (Cambridge, England : 2003) (2006) 46 5464-5475
a=10.7630(10)Å b=13.300(2)Å c=14.2690(10)Å
α=90.00° β=96.620(10)° γ=90.00°
Quinizarin
C14H8O4
CrystEngComm (2015) 17, 21 3985
a=10.2390(8)Å b=6.0429(4)Å c=16.454(2)Å
α=90° β=95.999(8)° γ=90°
Quinizarin
C14H8O4
CrystEngComm (2015) 17, 21 3985
a=20.0099(12)Å b=24.6219(9)Å c=18.3201(11)Å
α=90° β=116.274(8)° γ=90°
C19H13F2NO3
C19H13F2NO3
Chemical communications (Cambridge, England) (2020) 56, 42 5657-5660
a=3.8999(2)Å b=34.7661(18)Å c=11.4896(7)Å
α=90° β=94.404(5)° γ=90°
C8H15N2NaO2S2
C8H15N2NaO2S2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 31 10721-10736
a=15.2035(17)Å b=11.0876(11)Å c=15.0618(15)Å
α=90° β=111.081(13)° γ=90°
C9H14AuBr2NO2S2
C9H14AuBr2NO2S2
Dalton transactions (Cambridge, England : 2003) (2018) 47, 31 10721-10736
a=8.0665(4)Å b=16.5901(11)Å c=11.7403(6)Å
α=90° β=102.529(5)° γ=90°
C18H28N2O4S4Zn
C18H28N2O4S4Zn
Dalton transactions (Cambridge, England : 2003) (2018) 47, 31 10721-10736
a=9.4775(7)Å b=10.8781(8)Å c=12.1158(9)Å
α=81.181(6)° β=72.125(6)° γ=81.757(6)°
[Ni7(OH)6(L1)6](NO3)2.2MeOH
C56H66N8Ni7O26
Dalton Transactions (2010) 39, 20 4809
a=13.913(2)Å b=13.913(2)Å c=23.141(5)Å
α=90.00° β=90.00° γ=120.00°
[Zn7(OH)6(L1)6](NO3)2.2MeOH.H2O
C56H66N8O27Zn7
Dalton Transactions (2010) 39, 20 4809
a=13.902(2)Å b=13.902(2)Å c=23.353(5)Å
α=90.00° β=90.00° γ=120.00°
[Zn7(OH)6(immp)6](NO3)2.3MeNO2
C57H66N11O30Zn7
Dalton Transactions (2010) 39, 20 4809
a=14.082(2)Å b=14.082(2)Å c=22.759(5)Å
α=90.00° β=90.00° γ=120.00°
(Mn4F4(1,10-phen)8(NO3)4.12(H2O)
C96H88F4Mn4N20O24
Chemical communications (Cambridge, England) (2009) 45 7024-7026
a=26.912(4)Å b=26.912(4)Å c=13.231(3)Å
α=90.00° β=90.00° γ=90.00°
C21H18N4S
C21H18N4S
Journal of the Chemical Society, Perkin Transactions 1 (1999) 11 1415
a=9.2079(10)Å b=10.2328(10)Å c=10.764(2)Å
α=105.590(15)° β=99.435(13)° γ=91.538(11)°